Attachment and Prognostic Factor: the Implicit Approach
Launched by CENTRE HOSPITALIER HENRI LABORIT · Jun 29, 2021
Trial Information
Current as of July 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Attachment and Prognostic Factor: the Implicit Approach," is designed to better understand what factors influence the recovery of patients dealing with substance dependence, which means they have problems related to the use of drugs or alcohol. The study will involve five visits: an initial visit where patients will provide consent to participate and complete some questionnaires online, followed by four phone interviews to check in on their progress.
To be eligible for this study, participants need to be between 18 and 65 years old and must be receiving help for their substance use issues at the Henri Laborit Hospital. They should also be able to read and write in French and must agree to participate after being informed about the study. However, those who are involved in other specific trials or cannot complete the questionnaires will not be able to join. This study aims to gather valuable information that could help improve treatment for individuals struggling with addiction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between 18 and 65 years old
- • Patients with a use-related disorder as defined by DSM5
- • Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
- • Having expressed non-opposition to participating in the study after receiving written information.
- Exclusion Criteria:
- • Person who cannot read or write
- • Simultaneous participation in a therapeutic trial involving oxytocin
- • Patients protected by law
- • Patients who do not have French as their native language
- • Patients who, in the opinion of the investigator, are unable to complete the questionnaires
About Centre Hospitalier Henri Laborit
Centre Hospitalier Henri Laborit is a leading healthcare institution committed to advancing medical research and patient care through innovative clinical trials. With a focus on a multidisciplinary approach, the center integrates cutting-edge technology and evidence-based practices to investigate new treatments and improve health outcomes. The hospital collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to ensure that its clinical studies are conducted with the highest standards of ethics and scientific rigor. By fostering a culture of collaboration and excellence, Centre Hospitalier Henri Laborit aims to contribute significantly to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Wilfried SERRA, Dr
Principal Investigator
Centre Hospitalier Henri Laborit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials